EmPAC (reformulated paclitaxel)
/ Cornerstone Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 5
Of
5
Go to page
1
February 24, 2025
EMPAC-BDD: TMS Visual Modulation in Body Dysmorphic Disorder
(clinicaltrials.gov)
- P=N/A | N=40 | Recruiting | Sponsor: Centre for Addiction and Mental Health | Trial completion date: Oct 2024 ➔ Oct 2025 | Trial primary completion date: Jul 2024 ➔ Jul 2025
Trial completion date • Trial primary completion date • CNS Disorders • Psychosomatic Disorders
May 23, 2023
EMPAC-BDD: TMS Visual Modulation in Body Dysmorphic Disorder
(clinicaltrials.gov)
- P=N/A | N=40 | Recruiting | Sponsor: Centre for Addiction and Mental Health | Not yet recruiting ➔ Recruiting
Enrollment open • CNS Disorders • Psychosomatic Disorders
February 08, 2023
EMPAC-BDD: TMS Visual Modulation in Body Dysmorphic Disorder
(clinicaltrials.gov)
- P=N/A | N=40 | Not yet recruiting | Sponsor: Centre for Addiction and Mental Health | Initiation date: Dec 2022 ➔ Mar 2023
Trial initiation date • CNS Disorders • Psychosomatic Disorders
November 07, 2022
EMPAC-BDD: TMS Visual Modulation in Body Dysmorphic Disorder
(clinicaltrials.gov)
- P=N/A | N=40 | Not yet recruiting | Sponsor: Centre for Addiction and Mental Health
New trial • CNS Disorders • Psychosomatic Disorders
December 15, 2021
"Así se empacó la tuya @manu_barreiro jejejeje"
(@puentesfabi)
1 to 5
Of
5
Go to page
1